Cord Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationFetal BloodPeripheral Blood Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem CellsStem Cell TransplantationTransplantation, AutologousTransplantation ConditioningStem CellsGraft vs Host DiseaseMonocrotophosHematologic NeoplasmsPenile ImplantationBone Marrow TransplantationHematopoietic Stem Cell MobilizationAntigens, CD34Transplantation ChimeraGraft SurvivalTreatment OutcomeTissue DonorsBlood BanksMyeloablative AgonistsBusulfanMelphalanCombined Modality TherapyHistocompatibility TestingCell DifferentiationWhole-Body IrradiationGranulocyte Colony-Stimulating FactorHistocompatibilityRecurrenceMultiple MyelomaLiver TransplantationHematopoiesisRemission InductionLeukemiaRetrospective StudiesGraft vs Leukemia EffectLeukapheresisCyclophosphamideImmunosuppressive AgentsMesenchymal Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsVidarabineHematologic DiseasesDisease-Free SurvivalMice, SCIDSurvival RateCells, CulturedCell TransplantationChimerismTime FactorsLeukemia, Myeloid, AcuteEmbryonic Stem CellsSurvival AnalysisHLA AntigensKidney TransplantationMyelodysplastic SyndromesTransplantation, IsogeneicLymphoma, Non-HodgkinBlood Component RemovalAdult Stem CellsSalvage TherapyBone Marrow CellsHepatic Veno-Occlusive DiseaseSiblingsTransplantation ImmunologyAntineoplastic Agents, AlkylatingUnrelated DonorsInfectionCell LineageStem Cell NicheGraft vs Tumor EffectCytomegalovirus InfectionsPrecursor Cell Lymphoblastic Leukemia-LymphomaAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFollow-Up StudiesEtoposideFlow CytometryThiotepaLymphocyte TransfusionBone MarrowLymphocyte DepletionCytarabineHodgkin DiseaseBlood CellsColony-Forming Units AssayPluripotent Stem CellsImmunosuppressionAcute DiseaseAntilymphocyte SerumMesenchymal Stromal CellsT-LymphocytesDonor SelectionMice, Inbred NODOpportunistic InfectionsFatal OutcomeMice, Inbred C57BL